2155. Low prevalence of OXA-48-like carbapenemases and susceptibility to imipenem/relebactam among carbapenem-resistant non-Morganellaceae Enterobacterales isolates from Latin America – SMART 2018-2021

BACKGROUND: Imipenem/relebactam (IMI/REL) is a combination of imipenem/cilastatin with relebactam, an inhibitor of class A and C β-lactamases. IMI/REL is not active against metallo-β-lactamases (MBLs) or OXA-48-like carbapenemases. Using non-Morganellaceae Enterobacterales (NME) isolates collected i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Wise, Mark G, Siddiqui, Fakhar, Polis, Thales, DeRyke, C Andrew, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678720/
http://dx.doi.org/10.1093/ofid/ofad500.1778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678720/
http://dx.doi.org/10.1093/ofid/ofad500.1778

Ejemplares similares